Cite

HARVARD Citation

    Sandborn, W. et al. (n.d.). P035 ETROLIZUMAB TREATMENT MODULATES SOLUBLE MADCAM-1 LEVELS IN SERUM IN PATIENTS WITH CROHN'S DISEASE. Inflammatory bowel diseases. p. S17. [Online]. 
  
Back to record